KCNT1 and epilepsy: A single ICV injection of a Kcnt1 gapmer (i.e., short DNA strands flanked by strands of RNA mimics) ASO in a mouse model of KCNT1-epilepsy led to significant reduction in seizure frequency and increased overall survival compared to mice treated with a control (i.e., non-hybridizing) sequence (86).